Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on Iberdomide and Dexamethasone, Alone or with Drug Combination, for Newly Diagnosed Multiple Myeloma Patients Not Eligible for Transplant

    Not recruiting

    1 1 1
    Investigated drugs:
    Spain
  • Study on Murcidencel for Children, Adolescents, and Young Adults with High-Risk Progressive or Recurrent Metastatic Tumors

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Czechia
  • Study on Psilocybin, Ketamine, and Midazolam for Patients with Treatment-Resistant Depression

    Not recruiting

    1 1
    Investigated diseases:
    Czechia
  • PET Imaging with 89Zr-Atezolizumab in Patients with Large B-cell Lymphoma Undergoing CD19 CAR T-cell Therapy

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on Rituximab for Patients with Relapsing Polymyalgia Rheumatica to Reduce Steroid Use

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on Switching from Boosted Protease Inhibitors to Fostemsavir for People with HIV-1 with Limited Treatment Options

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Italy Spain
  • Study on Liraglutide for Weight Management in Children Aged 6 to 12 with Obesity

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Portugal
  • Study on the Safety and Tolerability of Elexacaftor, Tezacaftor, and Ivacaftor in Children with Cystic Fibrosis Aged 12 to Less Than 24 Months

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Denmark Germany The Netherlands
  • Study on Patient Preference for Subcutaneous Pembrolizumab with Hyaluronidase vs. Intravenous Pembrolizumab in Melanoma, Renal Cell Carcinoma, and Lung Cancer Patients

    Not recruiting

    1 1 1
    Investigated drugs:
    France Poland
  • Study of TAK-280, Tocilizumab, and Siltuximab for Patients with Advanced or Metastatic Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    France Spain